- 首頁
- App 分析
- Guardant Health Portal
- Guardant Health Portal Vs. Caris+
Guardant Health Portal 與 Caris+ 使用情況與統計
The Guardant Health iOS app is available for physicians and their staff to conveniently view Guardant Health reports on their iPhones and iPads.
Report Access:
Easily search, sort, and review reports as soon as they are made available.
Simple Sign-in:
Sign-in to your Guardant Health portal account with your username and password.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
The Caris+ App provides convenient access to manage and review Caris profiling cases. View current and past patient results whenever and wherever you are.
• View and search current and past cases
• Receive real-time case notifications
• Track testing progress
• Approve orders
• View interactive results and select clinical trial matches
• Request Caris Molecular Tumor Board review
• Share patient educational information
About Caris Life Sciences
Caris Life Sciences® is a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions.
Caris is also advancing precision medicine with Caris Artificial Intelligence, combining its market leading service offering, Caris Molecular Intelligence® with its proprietary artificial intelligence analytics engine, DEAN™. This information, coupled with mature clinical outcomes on thousands of patients, provides unmatched molecular solutions for patients, physicians, payers and biopharmaceutical organizations.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
Guardant Health Portal與 Caris+ 比較排名
比較過去 28 天的 Guardant Health Portal 排名趨勢與 Caris+
排名
無可用數據
各國 Guardant Health Portal vs. Caris+ 排名比較
比較過去 28 天的 Guardant Health Portal 排名趨勢與 Caris+
無可顯示數據
使用我們的免費試用版,與所有網站進行比較
Guardant Health Portal VS.
Caris+
1月 9, 2025